0002017131-25-000004.txt : 20251022 0002017131-25-000004.hdr.sgml : 20251022 20251022110317 ACCESSION NUMBER: 0002017131-25-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251022 DATE AS OF CHANGE: 20251022 EFFECTIVENESS DATE: 20251022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Andson Biotech Inc. CENTRAL INDEX KEY: 0002017131 ORGANIZATION NAME: EIN: 874041250 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-561640 FILM NUMBER: 251409140 BUSINESS ADDRESS: STREET 1: 1705 COMMERCE DR NW STREET 2: SUITE 100 CITY: ATLANTA STATE: GA ZIP: 30318 BUSINESS PHONE: 7273897725 MAIL ADDRESS: STREET 1: 1705 COMMERCE DR NW STREET 2: SUITE 100 CITY: ATLANTA STATE: GA ZIP: 30318 D 1 primary_doc.xml X0708 D LIVE 0002017131 Andson Biotech Inc. 1705 COMMERCE DR NW SUITE 100 ATLANTA GA GEORGIA 30318 7273897725 DELAWARE None None Corporation true 2021 Mason Chilmonczyk 1705 Commerce Dr NW Suite 100 Atlanta GA GEORGIA 30318 Executive Officer Director Andrei Fedorov 1705 Commerce Dr NW Suite 100 Atlanta GA GEORGIA 30318 Director Thomas O'Brien 1705 Commerce Dr NW Suite 100 Atlanta GA GEORGIA 30318 Director James Ross 1705 Commerce Dr NW Suite 100 Atlanta GA GEORGIA 30318 Director Jim Filippini 1705 Commerce Dr NW Suite 100 Atlanta GA GEORGIA 30318 Executive Officer Glenn Epstein 1705 Commerce Dr NW Suite 100 Atlanta GA GEORGIA 30318 Director Biotechnology Decline to Disclose 06b false 2025-10-17 false true false 0 5000000 4735000 265000 false 29 0 0 0 false Andson Biotech Inc. Mason Chilmonczyk Mason Chilmonczyk Chief Executive Officer 2025-10-22